Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

NETWORK 3OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 182Leukemia 128Lymphoma 91Leukemia, Myeloid, Acute 83Myelodysplastic Syndromes 64Burkitt Lymphoma 59Lymphoma, Non-Hodgkin 53Lymphoma, Large B-Cell, Diffuse 42Leukemia, Myeloid, Accelerated Phase 39Leukemia, Lymphocytic, Chronic, B-Cell 39Lymphoma, Mantle-Cell 38Hodgkin Disease 38Graft vs Host Disease 36Blast Crisis 35Congenital Abnormalities 34Multiple Myeloma 33Lymphoma, Follicular 33Leukemia, Myeloid, Chronic-Phase 33Myeloproliferative Disorders 32Recurrence 30Breast Neoplasms 29Leukemia, Myelomonocytic, Chronic 28Primary Myelofibrosis 26Lymphoma, Large-Cell, Immunoblastic 26Lymphoma, B-Cell, Marginal Zone 25Neoplasms, Plasma Cell 22Osteosarcoma 21Leukemia, Myelogenous, Chronic, BCR-ABL Positive 21Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 20Leukemia, Biphenotypic, Acute 20

Interventions

Gemcitabine 11Cisplatin 11Nivolumab 4Doxorubicin 4pembrolizumab 3avelumab 3Radiotherapy 3Fluorouracil 3Docetaxel 3Carboplatin 3vinflunine 2pegfilgrastim 2Sunitinib 2Platinum 2Paclitaxel 2Immunoglobulin G 2Ifosfamide 2Disulfides 21,2-diaminocyclohexaneplatinum II citrate 2vandetanib 1tremelimumab 1tocilizumab 1temsirolimus 1tamibarotene 1relatlimab 1merphos 1guadecitabine 1enzalutamide 1durvalumab 1dehydroftorafur 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Urethral Neoplasms × Methotrexate × Clear all
NCT01639521 2014-01-29

Gemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Urothelial Cancer

University of Southern California

Phase 2 Withdrawn
Genitourinary

Urinary Bladder Neoplasms, Ureteral Neoplasms, Urethral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡